These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 34303896)

  • 21. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
    Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.
    Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA
    Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
    Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
    Abouzid KAM; Al-Ansary GH; El-Naggar AM
    Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
    Abdelgawad MA; Labib MB; Abdel-Latif M
    Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
    Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA
    Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromone-based small molecules for multistep shutdown of arachidonate pathway: Simultaneous inhibition of COX-2, 15-LOX and mPGES-1 enzymes.
    Elzahhar PA; Orioli R; Hassan NW; Gobbi S; Belluti F; Labib HF; El-Yazbi AF; Nassra R; Belal ASF; Bisi A
    Eur J Med Chem; 2024 Feb; 266():116138. PubMed ID: 38219658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases.
    Elzahhar PA; Abd El Wahab SM; Elagawany M; Daabees H; Belal ASF; El-Yazbi AF; Eid AH; Alaaeddine R; Hegazy RR; Allam RM; Helmy MW; Bahaa Elgendy ; Angeli A; El-Hawash SA; Supuran CT
    Eur J Med Chem; 2020 Aug; 200():112439. PubMed ID: 32485532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
    Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
    Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents.
    Jan MS; Ahmad S; Hussain F; Ahmad A; Mahmood F; Rashid U; Abid OU; Ullah F; Ayaz M; Sadiq A
    Eur J Med Chem; 2020 Jan; 186():111863. PubMed ID: 31740050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives.
    Birgül K; Yıldırım Y; Karasulu HY; Karasulu E; Uba AI; Yelekçi K; Bekçi H; Cumaoğlu A; Kabasakal L; Yılmaz Ö; Küçükgüzel ŞG
    Eur J Med Chem; 2020 Dec; 208():112841. PubMed ID: 32998089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.
    Ganesh R; Marks DJ; Sales K; Winslet MC; Seifalian AM
    World J Surg Oncol; 2012 Sep; 10():200. PubMed ID: 23013454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking study.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2022 Mar; 120():105627. PubMed ID: 35065465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent.
    Omar YM; Abdel-Moty SG; Abdu-Allah HHM
    Bioorg Chem; 2020 Apr; 97():103657. PubMed ID: 32086052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines.
    Abdelkhalek AS; Kothayer H; Rezq S; Orabi KY; Romero DG; El-Sabbagh OI
    Eur J Med Chem; 2023 Aug; 256():115443. PubMed ID: 37182334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
    Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL
    Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.